The Protein Corona as a Confounding Variable of Nanoparticle-Mediated Targeted Vaccine Delivery
Nanocarriers (NC) are very promising tools for cancer immunotherapy. Whereas conventional vaccines are based on the administration of an antigen and an adjuvant in an independent fashion, nanovaccines can facilitate cell-specific co-delivery of antigen and adjuvant. Furthermore, nanovaccines can be...
Main Authors: | Matthias Bros, Lutz Nuhn, Johanna Simon, Lorna Moll, Volker Mailänder, Katharina Landfester, Stephan Grabbe |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2018.01760/full |
Similar Items
-
Unraveling the In Vivo Protein Corona
by: Johanna Simon, et al.
Published: (2021-01-01) -
Cellular Uptake of siRNA-Loaded Nanocarriers to Knockdown PD-L1: Strategies to Improve T-cell Functions
by: Raweewan Thiramanas, et al.
Published: (2020-09-01) -
Delivery of Immunostimulatory Cargos in Nanocarriers Enhances Anti-Tumoral Nanovaccine Efficacy
by: Jenny Schunke, et al.
Published: (2023-07-01) -
Uptake of extracellular vesicles into immune cells is enhanced by the protein corona
by: Laura Dietz, et al.
Published: (2023-12-01) -
Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses
by: Laura E. González-García, et al.
Published: (2022-02-01)